YM598

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YM598, covering 2012-06-07 to 2012-06-07. Get the full timeline:

Most recent: Clinical Trial Update: YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer [Phase 2]